Citadel Advisors’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-27,385
Closed -$23K 5041
2018
Q2
$23K Buy
+27,385
New +$23K ﹤0.01% 4024